T/CHATA 041-2024 Active Group standards

T/CHATA 041-2024 Guidelines for the Treatment of Rifampicin-Resistant Tuberculosis

T/CHATA 041-2024

Publish Date: 1970-01-01 Implement Date: 1970-01-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 49.00
Out of stock

Basic Information

Standard Code: T/CHATA 041-2024
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: -
ICS Name: -
Publish Date: 1970-01-01
Implement Date: 1970-01-01

Scope

This document stipulates the long-term and short-term treatment regimens for rifampicin-resistant tuberculosis, including the antituberculosis drugs to be used, the principles for formulating treatment regimens, the principles for adjusting treatment regimens, monitoring during treatment, indications for discontinuing treatment, and the classification of treatment outcomes. This document is applicable to the formulation and evaluation of standardized treatment regimens for drug-resistant tuberculosis in disease prevention and control institutions (tuberculosis prevention and control institutions) at all levels and specialized tuberculosis medical institutions.

Development Information

Word Count: 40 Thousand words

Related Standards

Contact Us